<![CDATA[
<p><font face="Arial, sans-serif"><span style="font-size: 16px;"><b><span style="font-size: 14pt;">보도자료</span></b></span></font></p><p><font face="Arial, sans-serif"><span style="font-size: 16px;"><b><span style="font-size: 14pt;"><br></span></b></span></font></p><p><b style="font-size: 16px; font-family: Arial, sans-serif;">Kyowa Kirin, 일본 파킨슨 병에 대한 새로운 경피 패치 HARUROPI® TAPE (HP-3000) 승인 발표</b></p><p><font face="Arial, sans-serif"><span style="font-size: 16px;"><b><br></b></span></font></p><p></p><p><font face="Arial, sans-serif"><span style="font-size: 16px;"><b>도쿄, 2019 년 9 월 20 일 --- Kyowa Kirin Co., Ltd. (도쿄 일본; 사장 : 미야모토 마사시, "교와 기린")는 오늘 Hisamitsu Pharmaceutical Co., Inc. (일본 사가 토스시; 회장 겸 CEO : 히로타카 나카 토미 (Hirotaka Nakatomi, "히사 미츠 제약 (Hisamitsu Pharmaceutical)")는 일본 보건 복지부 (MHLW)로부터 파킨슨병 치료를 위한 HARUROPI® TAPE 제조 및 마케팅 승인을 받았다.</b></span></font></p><p><b><span style="font-family: Arial, sans-serif; font-size: 12pt;"><br></span></b></p><p><b><span style="font-family: Arial, sans-serif; font-size: 12pt;">하루로피 테이프의 개요 <Summary of the HARUROPI® TAPE></span><br></b></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;"><b><br></b></span></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;"><b>상품명(Product Name)</b></span></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;">HARUROPI® TAPE 8mg</span></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;">HARUROPI® TAPE 16mg</span></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;">HARUROPI® TAPE 24mg</span></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;">HARUROPI® TAPE 32mg</span></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;">HARUROPI® TAPE 40mg</span></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;"><br></span></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;"><b>제네릭 이름(Generic Name):</b> 로피니롤 염산염(Ropinirole hydroch</span><span style="font-family: Arial, sans-serif; font-size: 12pt;">loride)</span></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;"><b>적응증(Indication):</b> 파킨슨병(Parkinson’s disease)</span></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;"><br></span></p><p><b><font face="Arial, sans-serif"><span style="font-size: 16px;">복용량 및 관리(</span></font><span style="font-size: 16px; font-family: Arial, sans-serif;">Dosage and Administration)</span></b></p><p><span style="font-size: 16px; font-family: Arial, sans-serif;">일반적으로 성인의 경우 처음에는 하루에 한 번 로피니롤 염산염으로 8 mg 제제를 적용하여 진행 상황을 관찰하고 필요에 따라 1 주일 이상의 간격으로 8 mg 씩 증가 한다. 복용량은 가슴, 복부, 측면, 허벅지 또는 팔뚝의 피부에 하루에 한 번 적용하고 24 시간마다 교체한다. 또한, 복용량은 연령 및 증상에 따라 조정될 수 있으며, 일일 복용량은 로피니롤 하이드로클로라이드 64 mg을 초과해서는 안된다.</span><br></p><div><br></div><p><span style="font-family: Arial, sans-serif; font-size: 12pt;">Usually, for adults initially apply 8 mg formulation as Ropinirole </span><span style="font-family: Arial, sans-serif; font-size: 12pt;">hydrochloride once daily, observing the progress, increased as needed the </span><span style="font-family: Arial, sans-serif; font-size: 12pt;">daily dose by 8 mg at intervals of 1 week or more. For any dose, apply </span><span style="font-family: Arial, sans-serif; font-size: 12pt;">once daily to the skin of the chest, abdomen, flank, thigh or upper arm </span><span style="font-family: Arial, sans-serif; font-size: 12pt;">and replace every 24 hours. Further, the dosage can be adjusted according </span><span style="font-family: Arial, sans-serif; font-size: 12pt;">to the age and the symptoms, the daily dosage should not exceed 64 mg </span><span style="font-family: Arial, sans-serif; font-size: 12pt;"> Ropinirole hydrochloride.</span></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;"><br></span></p><p><b><span style="font-family: Arial, sans-serif; font-size: 12pt;">제제의 크기(Size of the </span><span style="font-family: Arial, sans-serif; font-size: 12pt;">Formulation)</span></b></p><p><span style="color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif; font-size: 16px;">5.33cm² (HARUROPI</span><span style="overflow-wrap: break-word; word-break: keep-all; box-sizing: border-box; backface-visibility: hidden; font-size: 1.6rem; line-height: 0; vertical-align: baseline; position: relative; bottom: -0.25em; color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif;">®</span><span style="color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif; font-size: 16px;"> TAPE 8mg)</span><br style="overflow-wrap: break-word; word-break: keep-all; box-sizing: border-box; backface-visibility: hidden; font-size: 16px; color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif;"><span style="color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif; font-size: 16px;">10.67cm² (HARUROPI</span><span style="overflow-wrap: break-word; word-break: keep-all; box-sizing: border-box; backface-visibility: hidden; font-size: 1.6rem; line-height: 0; vertical-align: baseline; position: relative; bottom: -0.25em; color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif;">®</span><span style="color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif; font-size: 16px;"> TAPE 16mg)</span><br style="overflow-wrap: break-word; word-break: keep-all; box-sizing: border-box; backface-visibility: hidden; font-size: 16px; color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif;"><span style="color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif; font-size: 16px;">16.00cm² (HARUROPI</span><span style="overflow-wrap: break-word; word-break: keep-all; box-sizing: border-box; backface-visibility: hidden; font-size: 1.6rem; line-height: 0; vertical-align: baseline; position: relative; bottom: -0.25em; color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif;">®</span><span style="color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif; font-size: 16px;"> TAPE 24mg)</span><br style="overflow-wrap: break-word; word-break: keep-all; box-sizing: border-box; backface-visibility: hidden; font-size: 16px; color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif;"><span style="color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif; font-size: 16px;">21.33cm² (HARUROPI</span><span style="overflow-wrap: break-word; word-break: keep-all; box-sizing: border-box; backface-visibility: hidden; font-size: 1.6rem; line-height: 0; vertical-align: baseline; position: relative; bottom: -0.25em; color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif;">®</span><span style="color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif; font-size: 16px;"> TAPE 32mg)</span><br style="overflow-wrap: break-word; word-break: keep-all; box-sizing: border-box; backface-visibility: hidden; font-size: 16px; color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif;"><span style="color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif; font-size: 16px;">26.67cm² (HARUROPI</span><span style="overflow-wrap: break-word; word-break: keep-all; box-sizing: border-box; backface-visibility: hidden; font-size: 1.6rem; line-height: 0; vertical-align: baseline; position: relative; bottom: -0.25em; color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif;">®</span><span style="color: rgb(93, 97, 100); font-family: "Hind Madurai", Arial, sans-serif; font-size: 16px;"> TAPE 40mg)</span><br></p><p><br></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;">https://kyowakirin.com/media_center/news_releases/2019/pdf/e20190920_02.pdf</span><br></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;"><b><br></b></span></p><p><b>**************************************************************************************************</b></p><p><br></p><p style="text-align: center;"><img src="https://t1.daumcdn.net/cfile/cafe/99C3314C5D92A0202D" class="txc-image" actualwidth="474" hspace="1" vspace="1" border="0" width="474" exif="{}" data-filename="03220f8767a4cef628cb2217d3de8252fec26b43.jpg" style="clear:none;float:none;" id="A_99C3314C5D92A0202D7BE1"/></p><p style="text-align: left;"><br></p><p style="text-align: center;"><img src="https://t1.daumcdn.net/cfile/cafe/99C4C14C5D92A0212D" class="txc-image" actualwidth="474" hspace="1" vspace="1" border="0" width="474" exif="{}" data-filename="65c46ccd4ba0609fd7fc10aa727ea3988ff1a68c.jpg" style="clear:none;float:none;" id="A_99C4C14C5D92A0212D23D5"/></p><p style="text-align: left;"><br></p><p><span style="font-family: Arial, sans-serif; font-size: 12pt;"><b>* 귀한 정보를 올려 주신 보리님께 감사 드립니다*</b></span></p>
<!-- -->
]]>
카페 게시글
임상시험약소식
경피흡수형 파킨슨병 약 하루로피 테이프(Haruropi Tape)
다음검색
첫댓글 앗.. 패치 정보는요.. 사실은 며칠전에 어느분에게 부탁 받았는데..
제가 검색 잘 못해서 soir님에게 부탁했더니 검색해서 찾아주신거에요 ㅋㅋ 댓글 캡쳐도 함께.
여러모로 도와 주셔서 고맙습니다
보리님,soir님, 푸른희망님 감사합니다!
새로운 정보를 접할때마다 반가우면서,
엄마에게도 혹시나...하는 기대와 희망이 생겨서
좋아요~~~
보나님이닷~! 어머님이 45년생이시군요... 증후군에도 분명히 좋은 약이 개발될꺼에요^^
ㅎㅎ 넹 ~~ 보리님^^
보나님이 맞구나 ㅋㅋ
귀한 정보 고맙습니다^^
고맙습니다
귀한정보 감사합니다.